69 related articles for article (PubMed ID: 20150637)
41. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
42. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
Lister J; Rybka WB; Donnenberg AD; deMagalhaes-Silverman M; Pincus SM; Bloom EJ; Elder EM; Ball ED; Whiteside TL
Clin Cancer Res; 1995 Jun; 1(6):607-14. PubMed ID: 9816022
[TBL] [Abstract][Full Text] [Related]
43. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
44. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
Steenbruggen TG; Steggink LC; Seynaeve CM; van der Hoeven JJM; Hooning MJ; Jager A; Konings IR; Kroep JR; Smit WM; Tjan-Heijnen VCG; van der Wall E; Bins AD; Linn SC; Schaapveld M; Jacobse JN; van Leeuwen FE; Schröder CP; van Tinteren H; de Vries EGE; Sonke GS; Gietema JA
JAMA Oncol; 2020 Apr; 6(4):528-534. PubMed ID: 31999296
[TBL] [Abstract][Full Text] [Related]
45. High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.
Somlo G; Doroshow JH; Forman SJ; Odom-Maryon T; Lee J; Chow W; Hamasaki V; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Simpson J; Molina A
J Clin Oncol; 1997 Aug; 15(8):2882-93. PubMed ID: 9256132
[TBL] [Abstract][Full Text] [Related]
46. Maintenance immunotherapy in recurrent ovarian cancer: long term follow-up of a phase II study.
Recchia F; Di Orio F; Candeloro G; Guerriero G; Piazze J; Rea S
Gynecol Oncol; 2010 Feb; 116(2):202-7. PubMed ID: 19880164
[TBL] [Abstract][Full Text] [Related]
47. Secondary leukemia after autologous peripheral blood progenitor cell transplantation for breast cancer.
Sica S; Salutari P; Ciarli M; Piccirillo N; Laurenti L; Menichella G; Leone G
Leukemia; 1997 Nov; 11(11):1990-2. PubMed ID: 9369440
[No Abstract] [Full Text] [Related]
48. Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer.
Recchia F; Saggio G; Nuzzo A; Biondi E; Di Blasio A; Cesta A; Candeloro G; Alesse E; Rea S
J Immunother; 2006; 29(1):87-94. PubMed ID: 16365604
[TBL] [Abstract][Full Text] [Related]
49. Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.
Beitsch P; Lotzová E; Hortobagyi G; Pollock R
Surg Oncol; 1994 Aug; 3(4):211-9. PubMed ID: 7834112
[TBL] [Abstract][Full Text] [Related]
50. Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy.
Yamasaki S; Kan N; Harada T; Ichinose Y; Moriguchi Y; Li L; Sugie T; Kodama H; Satoh K; Ohgaki K
Breast Cancer Res Treat; 1993; 26(1):55-65. PubMed ID: 8400324
[TBL] [Abstract][Full Text] [Related]
51. Clinical study on treatment of mammary cancer by shenqi fuzheng injection in cooperation with chemotherapy.
Bo Y; Li HS; Qi YC; Lu MY
Chin J Integr Med; 2007 Mar; 13(1):37-40. PubMed ID: 17578316
[TBL] [Abstract][Full Text] [Related]
52. Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant.
Garantziotis S; Bhalla KS; Long GD; Vredenburgh JJ; Folz RJ
Respiration; 2002; 69(4):351-4. PubMed ID: 12169751
[TBL] [Abstract][Full Text] [Related]
53. Immunotherapy for breast cancer: is it feasible?
Clarke E
Immunotherapy; 2015; 7(11):1135-43. PubMed ID: 26567869
[No Abstract] [Full Text] [Related]
54. Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer.
Recchia F; Candeloro G; Necozione S; Accorsi P; Recchia CO; Tombolini V; Rea S
Anticancer Res; 2010 Jan; 30(1):209-15. PubMed ID: 20150637
[TBL] [Abstract][Full Text] [Related]
55. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
Recchia F; Saggio G; Cesta A; Alesse E; Gallo R; Necozione S; Rea S
Anticancer Res; 2005; 25(4):3149-57. PubMed ID: 16080579
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
57. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
[TBL] [Abstract][Full Text] [Related]
58. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
59. Gene therapy strategies for carcinoma of the breast.
Ruppert JM; Wright M; Rosenfeld M; Grushcow J; Bilbao G; Curiel DT; Strong TV
Breast Cancer Res Treat; 1997 Jun; 44(2):93-114. PubMed ID: 9232269
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
